Digital Breast Tomosynthesis (DBT) Equipment Market

Global Digital Breast Tomosynthesis (DBT) Equipment Market Size

The global digital breast tomosynthesis equipment market was valued at USD 1,982.64 million in 2025 and is estimated to reach USD 2,263 million in 2026, and is projected to reach USD 6,519 million by 2034, growing at a CAGR of 14.14% from 2026 to 2034.

MARKET DRIVERS

The growing incidence of breast cancer across the globe is the key factor driving the DBT Equipment market growth. According to National Breast Cancer Foundation, an estimated 268,600 with invasive breast cancer and 62,930 women with non-invasive (in situ) breast cancer were diagnosed in the United States in 2019. The death expectancy was estimated in 41,760 women. It is also projected 1 in 8 women in the United States develop breast cancer in their lifetime. Across the world, the North American region is estimated to witness huge demand for this DBT equipment due to the significant growth of breast cancer occurrence in this region.

Growing awareness among people towards 2D & 3D mammography, well-developed equipment for the treatment, and technological advancements in the techniques for the quick diagnosis and detection of breast lesions is further accelerating the market growth. Escalating expenditure on healthcare and rising awareness about the benefits associated with DBT across the world are also contributing to a significant boost to the global digital breast tomosynthesis market growth.

MARKET RESTRAINTS

The rising cost of breast cancer treatment & maintenance of installed technology hampers the digital breast tomosynthesis equipment market growth. Skilled experts or trained lab technicians/radiologists are required to use the equipment. The shortage of this skilled human resource is expected to impact the growth of the digital breast tomosynthesis equipment market to some level. Shortages of reimbursement policies from the government and non-government bodies and lack of complete knowledge regarding digital breast tomosynthesis in a few countries are further expected to obstruct market growth.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Product Insights

Based on product type, the DBT equipment segment is presently leading the market with the most significant shares and is predicted to continue its dominance throughout the forecast period. The growth of this segment is majorly attributed to a moderate increase in breast cancer throughout the world. Having sound knowledge related to digital breast tomosynthesis is boosting the market. The market growth is also due to the advantages offered by the new products launched.

The 3D up-gradation segment is estimated to have a quick growth rate during the forecast period due to the rising awareness among women related to the digital equipment being used to boost the market growth.

By End User Insights

Based on End User, the Hospitals captured a large market share. Its growth rate is projected to be nearly 15% for the forecast period.

Based on the End-User, the hospital's segment accounts for the highest revenue share and is projected to see significant growth in Indian hospitals during the forecast period. This segment is likely to extend with a CAGR of 14.9%, and the increase is due to the extensive records of women with breast cancer and other health problems related to the breast in the hospitals, boosting the market growth.

The diagnostic centers segment is estimated to have the quickest growth rate during the period. The increasing number of diagnostic centers globally is considered to accelerate the segment market growth.

REGIONAL ANALYSIS

North America Digital Breast Tomosynthesis (DBT) Equipment Market Analysis

In 2024, the North American market dominated the global DBT equipment market and was estimated to retain its leading position throughout the forecast period. During the forecast period, the United States dbt equipment market is expected to showcase domination in the North American market. The Canadian market is estimated to register a healthy growth rate. North American countries such as the United States and Canada have a high prevalence of breast cancer, which is estimated to provide immense market growth. Notably, the U.S. has the highest share in North America. This region has a 55.1% share in terms of value. The increase is due to the colossal occurrence of breast cancer and also better healthcare infrastructure provided.

Europe Digital Breast Tomosynthesis (DBT) Equipment Market Analysis

Europe is very close to North America and was the second-largest regional market in 2023. The U.K. is predicted to lead the European market due to technological advancements. Also, increasing awareness among women regarding the DBT and its early diagnosis is one factor propelling the U.K. dbt equipment market growth.

Asia Pacific Digital Breast Tomosynthesis (DBT) Equipment Market Analysis

The Asia Pacific is the fastest-growing regional market and is the most lucrative region for DBT Equipment Market. Within the Asia Pacific, China accounted for the largest market share in this market.

Latin America Digital Breast Tomosynthesis (DBT) Equipment Market Analysis

Latin America was expected to reach a value of USD 273.18 million by 2032. This region is observed to have sluggish growth steadily throughout the period and also less market perception. In this region, the hospital's segment is accounted to have a growth rate of 15% along the period.

Middle East & Africa Digital Breast Tomosynthesis (DBT) Equipment Market Analysis

Middle East & Africa is another region to have inclined growth during the forecast period. This region size is expected to have a value of USD 165.52 billion by 2032, with a CAGR value of 11.6%. The growth in this region is due to low acceptable government policies and is likely to have less penetration market.

KEY MARKET PARTICIPANTS

Some notable companies operating in the global digital breast tomosynthesis (DBT) equipment market profiled in the report are

• Hologic Inc.
• Siemens Healthineers
• Fujifilm Corporation
• G.E. Healthcare
• Internazionale Medico Scientifica S.r.l
• Planmed Oy

GLOBAL DIGITAL BREAST TOMOSYNTHESIS (DBT) EQUIPMENT MARKET NEWS

• On January 24, 2020, Fujifilm Corporation introduced its new mammography imaging technique with the advanced technologies for Aspire Cristalle, a digital breast tomosynthesis that includes S-view.
• On November 12, 2019, Hologic Inc. received approval from the FDA for its 3DQuorum Imaging Technology which was powered by Genius A.I. This technology works in deuce with high clarity H.D. high-resolution imaging technology that decreases the tomosynthesis image level for radiologists by 66%.
• On July 24, 2013, G.E. Healthcare received a CE mark to approve SenoClaire tomosynthesis with 3D capacity. This device uses constant restoration of data collected from the images taken when screening or examining the breast is performed from different angles. Also, the system lowers the dosage used for analysis which helps in detecting breast cancer.
• On March 24, 2017, the Senographe Pristina system, a three-dimensional digital breast tomosynthesis system developed, was launched by G.E. Healthcare. Senographe Pristina has a feature that can handheld remote control called Pristina Dueta. Technology enhances the visualization of breast lesions with lower X-ray doses.

MARKET SEGMENTATION

This market research report on the global digital breast tomosynthesis (DBT) equipment market has been segmented based on the product, end-user, and region.

By Product

• 3-D Upgradation

• DBT Equipment

By End User

• Hospitals

• Diagnostic centers

By Region

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East and Africa